S. Dacic

发表

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

J. Austin, A. Nicholson, L. Chirieac, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comprehensive genomic characterization of squamous cell lung cancers

Steven J. M. Jones, Joshua M. Stuart, Brian D. O’Connor, 2012, Nature.

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Benjamin Solomon, Neal I. Lindeman, Dara L. Aisner, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY.

Prasad Adusumilli, Young Tae Kim, Ugo Pastorino, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pathologic Assessment of Lung Squamous Cell Carcinoma After Neoadjuvant Immunotherapy.

I. Wistuba, W. Travis, S. Dacic, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

HepPar-1 expression in primary lung adenocarcinoma.

S. Dacic, S. Yousem, S. Lale, 2013, American journal of clinical pathology.

Robyn L. Temple-Smolkin, M. Ladanyi, Christina B. Ventura, 2018, Archives of pathology & laboratory medicine.

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center

N. Le Stang, N. Girard, A. Nicholson, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Molecular characterization of pleomorphic mesothelioma: a multi-institutional study

N. Le Stang, F. Galateau-Sallé, S. Dacic, 2021, Modern Pathology.

Pleural mesothelioma classification update

F. Galateau-Sallé, M. Beasley, S. Dacic, 2021, Virchows Archiv.

EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.

S. Armato, P. Courtiol, N. Girard, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas

N. Le Stang, F. Galateau-Sallé, M. Beasley, 2019, Modern Pathology.

The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.

F. Galateau-Sallé, L. Chirieac, A. Marchevsky, 2017, Human pathology.

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.

A. Gown, A. Nicholson, F. Galateau-Sallé, 2018, Archives of pathology & laboratory medicine.

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

A. Krasinskas, R. Seethala, S. Dacic, 2016, Modern Pathology.

Gray-Level Co-Occurrence Matrix Analysis of Granule Neurons of the Hippocampal Dentate Gyrus Following Cortical Injury

S. Dacic, I. Pantic, S. Pantic, 2020, Microscopy and Microanalysis.

Discriminatory ability of fractal and grey level co-occurrence matrix methods in structural analysis of hippocampus layers.

S. Dacic, I. Pantic, S. Pantic, 2015, Journal of theoretical biology.

Time is up for PD-L1 testing standardization in lung cancer.

S. Dacic, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas

Simion I. Chiosea, A. Krasinskas, Kisha Mitchell, 2008, Modern Pathology.

The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.

A. Krasinskas, S. Monaco, S. Dacic, 2011, American journal of clinical pathology.

Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.

J. Luketich, S. Dacic, S. Ramalingam, 2006, American journal of clinical pathology.

Bronchoscopic and transthoracic cytology and biopsy for pulmonary nonsmall cell carcinomas: Performance characteristics by procedure and tumor type

S. Dacic, N. P. Ohori, N. Tochigi, 2012, Diagnostic cytopathology.

DOG1: a novel marker of salivary acinar and intercalated duct differentiation

Simion I. Chiosea, Daniel J. Shiwarski, R. Seethala, 2012, Modern Pathology.

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.

David L. Gibbs, Benjamin E. Gross, Zachary J. Heins, 2018, Cancer discovery.

The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis.

A. Nicholson, F. Galateau-Sallé, L. Chirieac, 2021, Pathology.

Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology

F. Galateau-Sallé, S. Monaco, S. Dacic, 2020, Cancer cytopathology.

Whole exome sequencing reveals BAP1 somatic abnormalities in mesothelioma in situ.

F. Galateau-Sallé, S. Dacic, A. Churg, 2020, Lung cancer.

Malignant mesothelioma in situ: morphologic features and clinical outcome

F. Galateau-Sallé, S. Dacic, M. Tsao, 2019, Modern Pathology.

Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019

C. Cordon-Cardo, M. Fowkes, S. Dacic, 2021, The Journal of Infectious Diseases.

Broad SARS-CoV-2 cell tropism and immunopathology in lung tissues from fatal COVID-19

C. Cordon-Cardo, M. Fowkes, S. Dacic, 2021, The Journal of infectious diseases.

Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline From the College of American Pathologists in Collaboration With the American College of Chest Physicians, Association for Molecular Pathology, American Society of Cytopathology, American Thoracic

Brooke L. Billman, Claire W Michael, Sinchita Roy-Chowdhuri, 2020, Archives of pathology & laboratory medicine.

Pattern of chondroitin sulfate proteoglycan expression after ablation of the sensorimotor cortex of the neonatal and adult rat brain

S. Dacic, M. Stojiljkovic, I. Bjelobaba, 2008 .

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas

F. Galateau-Sallé, C. Comin, F. Demirağ, 2008, Virchows Archiv.

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma

A. Gown, A. Nicholson, F. Galateau-Sallé, 2017 .

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

A. Gown, A. Nicholson, F. Galateau-Sallé, 2013, Archives of pathology & laboratory medicine.

CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival

A. Krasinskas, S. Dacic, D. Bartlett, 2010, Modern Pathology.

State‐of‐the‐art cytology of pleural fluid, focusing on the diagnosis of mesothelioma

S. Monaco, S. Dacic, L. Brčić, 2021, Cytopathology : official journal of the British Society for Clinical Cytology.

Malignant Mesothelioma In Situ: Clinical and Pathologic Implications.

F. Galateau-Sallé, S. Dacic, A. Churg, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.

R. Dhir, J. Siegfried, M. Romkes, 2013, Cancer epidemiology.

Prognostic significance of microscopic size in peripherally located scar-associated clinical stage I lung carcinomas.

L. Pantanowitz, S. Dacic, D. Hartman, 2020, Lung cancer.

Altered p53 in microdissected, metachronous, premalignant and malignant oral lesions from the same patients

S. Dacic, E. Munck‐Wikland, J. Mcdonald, 1995, Clinical molecular pathology.

Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH

S. Monaco, S. Dacic, U. Rao, 2010, CytoJournal.

Pros: the present classification of mucinous adenocarcinomas of the lung.

S. Dacic, 2007, Translational lung cancer research.

Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.

S. Dacic, N. P. Ohori, N. Tochigi, 2011, American journal of clinical pathology.

EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.

Simion I. Chiosea, S. Dacic, M. Nikiforova, 2010, Human pathology.

Immunohistochemical Profile of Cystosarcoma Phyllodes of the Breast: A Study of 23 Cases

S. Dacic, S. Kounelis, E. Kouri, 2002, The breast journal.

Encapsulated follicular variant of papillary thyroid carcinoma.

S. Dacic, J. Hunt, E. Barnes, 2002, American journal of clinical pathology.

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

Iver Petersen, Elisabeth Brambilla, Ignacio Wistuba, 2012, Modern Pathology.

Advanced Lung Disease and Lung Transplantation 2-1-2011 The HLA Class II Allele Allele DRB 1 * 15 is over-represented in patients with Idiopathic Pulmonary Fibrosis

I. Noth, G. Rosen, F. Sciurba, 2013 .

The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis

I. Noth, G. Rosen, F. Sciurba, 2011, PloS one.

The HLA Class II Allele DRB 1 * 1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis

I. Noth, G. Rosen, F. Sciurba, 2011 .

Minimally Invasive Adenocarcinomas of the Lung

S. Dacic, 2009, Advances in anatomic pathology.

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society.

A. Borczuk, M. Mino‐Kenudson, Y. Yatabe, 2016, Archives of Pathology & Laboratory Medicine.

Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer

J. Luketich, J. Siegfried, S. Dacic, 2000, Annals of Surgical Oncology.

Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC).

A. Iafrate, M. Socinski, S. Ou, 2014 .

Malignant mesothelioma in situ

S. Dacic, A. Churg, H. Hwang, 2018, Histopathology.

Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma

A. Krasinskas, A. Borczuk, S. Dacic, 2016, Histopathology.

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas.

Caitlyn A. Miller, S. Dacic, A. Churg, 2018, Archives of pathology & laboratory medicine.

Neuroendocrine Lung Tumors

S. Dacic, 2010 .

Microsatellite instability is uncommon in lymphoepithelioma-like carcinoma of the lung.

S. Dacic, A. Sepulveda, J. Hunt, 2007, American journal of clinical pathology.

Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence

J. Herman, T. Burns, S. Dacic, 2017, The Journal of Biological Chemistry.

Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity

Caitlyn A. Miller, R. Seethala, S. Dacic, 2017, Modern Pathology.

Profi ling of Multifocal Tumors Using Next-Generation Sequencing Identifi es Concordant Occurrence of BRAF V600E Mutations

S. Dacic, M. Nikiforova, Y. Nikiforov, 2015 .

KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas

A. Krasinskas, S. Dacic, S. Chiosea, 2014, Modern Pathology.

Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer

J. Siegfried, S. Dacic, L. Stabile, 2017, Oncotarget.

Combined Analysis of Estrogen Receptor β-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome

R. Dhir, J. Siegfried, J. Grandis, 2010, Clinical Cancer Research.

Imaging , Diagnosis , Prognosis Combined Analysis of Estrogen Receptor b-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome

R. Dhir, J. Siegfried, J. Grandis, 2010 .

Applications of Molecular Tests in Anatomic Pathology

S. Dacic, J. Hunt, 2008 .

Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.

S. Dacic, S. Finkelstein, S. Yousem, 2004, Archives of pathology & laboratory medicine.

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non–small cell lung cancer

M. Socinski, J. Siegfried, T. Burns, 2017, Cancer.

Applications in Anatomic Pathology

S. Dacic, J. Hunt, 2009 .

Gross Cystic Disease Fluid Protein—(GCDFP-15): Expression in Primary Lung Adenocarcinoma

S. Dacic, S. Yousem, Joan M. Striebel, 2008, The American journal of surgical pathology.

Protein expression and gene amplification of epidermal growth factor receptor in thymomas

S. Dacic, D. Ionescu, M. Nola, 2005, Cancer.

Dilemmas in lung cancer staging.

S. Dacic, 2012, Archives of pathology & laboratory medicine.

Patterns of Allelic Loss of Synchronous Adenocarcinomas of the Lung

S. Dacic, S. Finkelstein, S. Yousem, 2005, The American journal of surgical pathology.

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.

S. Monaco, S. Dacic, M. Nikiforova, 2010, Human pathology.

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas

S. Dacic, M. Nikiforova, S. Yousem, 2010, Modern Pathology.

RET Rearrangements in Lung Adenocarcinoma and Radiation

M. Socinski, J. Siegfried, S. Dacic, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.

L. Chirieac, S. Dacic, J. Hornick, 2012, American journal of clinical pathology.

Secretory Myoepithelial Carcinoma: A Histologic and Molecular Survey and a Proposed Nomenclature for Mucin Producing Signet Ring Tumors

R. Seethala, S. Dacic, B. Purgina, 2014, Head and Neck Pathology.

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

A. Nicholson, A. Borczuk, A. Warth, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

A. Iafrate, L. Chirieac, M. Mino‐Kenudson, 2009, Clinical Cancer Research.

Genomic pathology: challenges for implementation.

S. Dacic, T. Allen, P. Cagle, 2011, Archives of pathology & laboratory medicine.

Small-cell neuroendocrine carcinoma displays unique profiles of tumor-suppressor gene loss in relationship to the primary site of formation.

S. Dacic, S. Finkelstein, S. Yousem, 2002, Human pathology.

Sex-determining region Y-box 2 amplification in preneoplastic squamous lesions of the lung.

S. Dacic, Alyssa Luvison, F. Schneider, 2013, Human pathology.

Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.

A. Nicholson, S. Dacic, M. Nikiforova, 2009, Human pathology.

Nodular Amyloidoma and Primary Pulmonary Lymphoma with Amyloid Production: A Differential Diagnostic Problem

S. Dacic, T. Colby, S. Yousem, 2000, Modern Pathology.

The HLA Class II Allele Allele DRB 1 * 15 is over-represented in patients with Idiopathic Pulmonary Fibrosis

I. Noth, G. Rosen, F. Sciurba, 2017 .

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

G. Giaccone, M. Ladanyi, M. Beasley, 2013, Archives of pathology & laboratory medicine.

Reply to verification bias in diagnostic accuracy studies for fine‐needle aspiration cytology

L. Pantanowitz, S. Monaco, S. Dacic, 2014, Cancer cytopathology.

Recent Advances in the Diagnosis of Malignant Mesothelioma: Focus on Approach in Challenging Cases and in Limited Tissue and Cytologic Samples

S. Monaco, S. Dacic, M. Mehrad, 2018, Advances in anatomic pathology.

2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.

S. Dacic, E. Jackson, Xi-chen Zhang, 2006, Vascular pharmacology.

Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: Clinical and histopathological evaluation

Saša Virijević Jovanović, L. Rakić, S. Dacic, 2008, Journal of the Neurological Sciences.

0818FED SUPP_Glioma.indd

S. Dacic, H. Colman, R. Przygodzki, 2018 .

Histologic classification of idiopathic chronic interstitial pneumonias.

S. Dacic, S. Yousem, 2003, American journal of respiratory cell and molecular biology.

Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing

B. Halmos, S. Dacic, P. Ma, 2022, JTO clinical and research reports.

Significance of a solitary perivascular mononuclear infiltrate in lung allograft recipients with mild acute cellular rejection.

S. Dacic, S. Yousem, A. Iacono, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Genotypic analysis of pulmonary Langerhans cell histiocytosis.

S. Dacic, S. Finkelstein, S. Yousem, 2003, Human pathology.

Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy

S. Dacic, S. Yousem, 2005, Modern Pathology.

Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.

Jian Yu, J. Siegfried, S. Dacic, 2008, Carcinogenesis.

Vitamin B Complex Treatment Attenuates Local Inflammation after Peripheral Nerve Injury

S. Dacic, B. B. Božić Nedeljković, S. Peković, 2019, Molecules.

Hyperbaric Oxygen Therapy in Traumatic Brain Injury: Cellular and Molecular Mechanisms Hyperbaric Oxygen Therapy in Traumatic Brain Injury: Cellular and Molecular Mechanisms

S. Dacic, M. Djelic, R. Jeremic, 2018 .

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Robert Brian Jenkins, Marc Ladanyi, Philip T Cagle, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

A. Nicholson, A. Borczuk, G. Scagliotti, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The 2021 WHO Classi ﬁ cation of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?

A. Nicholson, W. Travis, S. Dacic, 2022 .

Dynamic changes in the expression pattern of ecto‐5′‐nucleotidase in the rat model of cortical stab injury

L. Rakić, S. Dacic, N. Nedeljkovic, 2011, Journal of neuroscience research.

Effect of Vitamin B Complex Treatment on Macrophages to Schwann Cells Association during Neuroinflammation after Peripheral Nerve Injury

S. Dacic, B. B. Nedeljković, S. Peković, 2020, Molecules.

The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.

L. Rakić, S. Dacic, I. Božić, 2012, Journal of pharmacological sciences.

The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

N. Le Stang, A. Borczuk, I. Wistuba, 2022, Journal of Thoracic Oncology.

The 2021 WHO Classi ﬁ cation of Tumors of the Pleura: Advances Since the 2015 Classi ﬁ cation

A. Nicholson, F. Galateau-Sallé, W. Travis, 2022 .

Chordoid Glioma: A Case Report and Molecular Characterization of Five Cases

R. McLendon, D. Brat, S. Dacic, 2009, Brain pathology.

Combined treatment with ribavirin and tiazofurin attenuates response of glial cells in experimental autoimmune encephalomyelitis

S. Dacic, N. Nedeljkovic, I. Bjelobaba, 2012 .

Multicenter phase II study of cetuximab (C) with concomitant radiotherapy (RT) followed by consolidation chemotherapy (CT) in locally advanced non-small cell lung cancer (NSCLC).

D. Heron, J. Luketich, S. Dacic, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative image analysis for CD8 score in lung small biopsies and cytology cell‐blocks

L. Pantanowitz, S. Monaco, S. Dacic, 2020, Cytopathology : official journal of the British Society for Clinical Cytology.

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society.

M. Mino‐Kenudson, Y. Yatabe, M. Beasley, 2017, Archives of pathology & laboratory medicine.

Molecular Pathogenesis of Pulmonary Carcinosarcoma as Determined by Microdissection-Based Allelotyping

S. Dacic, S. Finkelstein, S. Yousem, 2002, The American journal of surgical pathology.

Reproducibility for histologic parameters in peritoneal mesothelioma.

A. Krasinskas, A. Borczuk, S. Dacic, 2017, Human pathology.

Syngeneic tobacco carcinogen–induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden

T. Burns, S. Dacic, C. Bakkenist, 2020, JCI insight.

Comprehensive molecular profiling of lung adenocarcinoma

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2014, Nature.

Chapter 12 – Immunohistology of Lung and Pleural Neoplasms

S. Dacic, S. Hammar, 2011 .

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.

Akihiko Yoshida, Mari Mino-Kenudson, Arne Warth, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Immunohistological Determination of Ecto-nucleoside Triphosphate Diphosphohydrolase1 (NTPDase1) and 5′-nucleotidase in Rat Hippocampus Reveals Overlapping Distribution

L. Rakić, S. Dacic, N. Nedeljkovic, 2007, Cellular and Molecular Neurobiology.

Solid papillary mesothelial tumor

N. Le Stang, F. Galateau-Sallé, S. Dacic, 2021, Modern Pathology.

Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.

R. Seethala, S. Dacic, J. Hunt, 2011, Human pathology.

A Reappraisal of the MECT1/MAML2 Translocation in Salivary Mucoepidermoid Carcinomas

R. Seethala, S. Dacic, M. Nikiforova, 2010, The American journal of surgical pathology.

Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: Clinical Implications

Simion I. Chiosea, R. Seethala, S. Dacic, 2012, The Laryngoscope.

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of Thoracic Oncology.

PD-L1 Testing for Lung Cancer in 2019: Perspective from the IASLC Pathology Committee.

N. Girard, A. Nicholson, A. Borczuk, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.

A. Borczuk, M. Mino‐Kenudson, Y. Yatabe, 2016, Archives of pathology & laboratory medicine.

Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging

J. Davison, S. Dacic, D. Strollo, 2016, Modern Pathology.

Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation.

R. Seethala, S. Dacic, E. Barnes, 2011, Archives of pathology & laboratory medicine.

Pentagastrin cytoprotection in ethanol-induced gastric mucosal lesions in rats.

S. Dacic, P. Sikiric, S. Seiwerth, 1993, Zentralblatt fur Veterinarmedizin. Reihe A.

Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production.

L. Rakić, S. Dacic, N. Nedeljkovic, 2008, International immunopharmacology.

Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome12

J. Siegfried, M. Romkes, J. Weissfeld, 2015, Neoplasia.

Fluorescence in situ Hybridization in Cytopathology

S. Monaco, S. Dacic, 2020 .

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer

Pengyuan Liu, S. Dacic, M. Nikiforova, 2014, Proceedings of the National Academy of Sciences.

The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

R. Seethala, S. Dacic, M. Nikiforova, 2010, Archives of pathology & laboratory medicine.

Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer

Jian Yu, J. Siegfried, S. Dacic, 2008 .

MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma

N. Le Stang, F. Galateau-Sallé, S. Dacic, 2019, Modern Pathology.

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of Thoracic Oncology.

Scientific Advances in Thoracic Oncology 2016.

H. Groen, C. Rudin, R. Rami-Porta, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.

A. Borczuk, M. Mino‐Kenudson, Y. Yatabe, 2016, Archives of pathology & laboratory medicine.

Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinoma

M. Socinski, D. Davar, T. Burns, 2015, Experimental Hematology & Oncology.

KRAS mutant allele-specific imbalance in lung adenocarcinoma

Simion I. Chiosea, S. Dacic, S. Chiosea, 2011, Modern Pathology.

Molecular Targeted Therapy of Lung Cancer

S. Dacic, 2012 .

Comprehensive molecular profiling of lung adenocarcinoma

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2014, Nature.

KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma

Caitlyn A. Miller, S. Dacic, W. LaFramboise, 2018, Histopathology.

ATM protein is deficient in over 40% of lung adenocarcinomas

J. Siegfried, T. Conrads, S. Dacic, 2016, Oncotarget.

FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.

Sara E Monaco, S. Monaco, S. Dacic, 2016, American journal of clinical pathology.

G. Giaccone, M. Ladanyi, M. Beasley, 2013, The Journal of molecular diagnostics : JMD.

Usefulness of methylthioadenosine phosphorylase and BRCA‐associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens

S. Dacic, A. Churg, Kyra B. Berg, 2019, Cancer cytopathology.

The 2021 World Health Organization Classification of Tumors of the Pleura: Advances since the 2015 Classification.

A. Nicholson, F. Galateau-Sallé, W. Travis, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The 2021 World Health Organization Classification of Tumors of the Thymus and Mediastinum: What's new in thymic epithelial, germ cell and mesenchymal tumors?

A. Nicholson, A. Marx, S. Dacic, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma

Simion I. Chiosea, M. Socinski, J. Siegfried, 2013, Cancer.

Pleural mesothelioma classification—update and challenges

S. Dacic, 2021, Modern Pathology.

Overexpression of Dicer in precursor lesions of lung adenocarcinoma.

Simion I. Chiosea, Robert W Sobol, Uma Chandran, 2007, Cancer research.

Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.

Patricia A. Young, R. Elashoff, J. Siegfried, 2018, Lung cancer.

Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.

J. Siegfried, S. Dacic, J. Kolesar, 2009, Lung cancer.

ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma

S. Dacic, M. Nikiforova, A. Mahaffey, 2016, Oncotarget.

Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.

J. Siegfried, S. Dacic, S. Land, 2005, Carcinogenesis.

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

I. Wistuba, M. Mino‐Kenudson, F. Hirsch, 2022 .

Comparison of PD‐L1 immunohistochemistry assays and response to PD‐1/L1 inhibitors in advanced non‐small‐cell lung cancer in clinical practice

S. Dacic, B. Kurland, C. Herbst, 2018, Histopathology.

PD‐L1 Immunohistochemistry Comparability Study in Real‐Life Clinical Samples: Results of Blueprint Phase 2 Project

Hui Yu, Keith M. Kerr, Ignacio Wistuba, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Precision Molecular Pathology of Lung Cancer

A. Borczuk, L. Chirieac, M. Beasley, 2017, Molecular Pathology Library.

miRNA expression profiling of lung adenocarcinomas: correlation with mutational status

S. Dacic, M. Nikiforova, Yongli Shuai, 2010, Modern Pathology.

p16 Deletion in sarcomatoid tumors of the lung and pleura.

L. Chirieac, S. Dacic, T. Allen, 2013, Archives of pathology & laboratory medicine.

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

A. Nicholson, A. Borczuk, L. Chirieac, 2018, Journal of Thoracic Oncology.

Molecular diagnostics of lung carcinomas.

S. Dacic, 2011, Archives of pathology & laboratory medicine.

Targeted Therapies in Lung Cancer.

L. Chirieac, S. Dacic, Sanja Dacic, 2010, Surgical pathology clinics.

Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2.

Y. Yatabe, S. Dacic, J. Goldman, 2023, Clinical lung cancer.

Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA

M. Tsuboi, Y. Yatabe, S. Dacic, 2021, Future oncology.

Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist.

A. Nicholson, F. Galateau-Sallé, V. Rusch, 2018, Archives of pathology & laboratory medicine.

Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections

Andrew D Althouse, S. Dacic, A. Althouse, 2015, Modern Pathology.

Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.

S. Dacic, S. Finkelstein, S. Yousem, 2005, Experimental and molecular pathology (Print).

Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations.

Yuri E Nikiforov, Marina Nikiforova, S. Dacic, 2013, Chest.

Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma.

A. Nicholson, F. Galateau-Sallé, A. Marchevsky, 2021, American journal of clinical pathology.

Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center.

G. Wainrib, P. Courtiol, C. Maussion, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer.

N. Le Stang, A. Nicholson, A. Borczuk, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Translocation Testing of Lung Cancer Biomarkers

S. Dacic, 2018 .

Histopathologic and molecular approach to staging of multiple lung nodules.

S. Dacic, F. Schneider, 2017, Translational lung cancer research.

Lung Carcinoma Staging Update.

S. Dacic, 2017, Archives of pathology & laboratory medicine.

Deep-learning based classification distinguishes sarcomatoid malignant mesotheliomas from benign spindle cell mesothelial proliferations

Adrian B Levine, A. Bashashati, L. Chirieac, 2021, Modern Pathology.

SULF2 Methylation is Prognostic for Lung Cancer Survival and Increases Sensitivity to Topoisomerase-I inhibitors via Induction of ISG15

J. Siegfried, S. Dacic, S. Belinsky, 2011, Oncogene.

The Pathologists' Conundrum.

S. Schnitt, D. Rimm, S. Dacic, 2022, Archives of pathology & laboratory medicine.

Defining morphologic features of invasion in pulmonary non-mucinous adenocarcinoma with lepidic growth - A proposal by the IASLC Pathology Committee.

A. Nicholson, A. Borczuk, W. Travis, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study

A. Nicholson, I. Petersen, L. Chirieac, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer

S. Dacic, A. Argiris, C. Belani, 2010, Clinical Cancer Research.

Cancer Therapy : Clinical Phase II Study of Everolimus ( RAD 001 ) in Previously Treated Small Cell Lung Cancer

S. Dacic, A. Argiris, C. Belani, 2010 .

EGFR expression stratifies oligodendroglioma behavior.

S. Dacic, C. Horbinski, R. Hamilton, 2011, The American journal of pathology.

Molecular Testing of Lung Carcinomas

S. Dacic, 2014 .

Present and Future Molecular Testing of Lung Carcinoma

S. Dacic, M. Nikiforova, 2014, Advances in Anatomic Pathology.

Molecular genetic testing for lung adenocarcinomas: a practical approach to clinically relevant mutations and translocations

S. Dacic, 2013, Journal of Clinical Pathology.

Molecular testing in lung carcinoma: Quo vadis?

S. Dacic, S. Yousem, 2010, American Journal of Clinical Pathology.

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

M. Mino‐Kenudson, Y. Yatabe, M. Beasley, 2016, Archives of pathology & laboratory medicine.

Robyn L. Temple-Smolkin, M. Ladanyi, Christina B. Ventura, 2018, The Journal of molecular diagnostics : JMD.

Artificial intelligence (AI)–powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer: Results from the LCMC3 study.

M. Kris, V. Rusch, I. Wistuba, 2021 .

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.

D. Heron, R. Seethala, Lin Wang, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.

J. Siegfried, S. Dacic, S. Land, 2012, Carcinogenesis.

Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.

D. Jukic, R. Dhir, C. Athanassiou, 2010, Human pathology.

Clear Cell Odontogenic Carcinomas Show EWSR1 Rearrangements: A Novel Finding and a Biological Link to Salivary Clear Cell Carcinomas

C. Antonescu, R. Seethala, S. Dacic, 2013, The American journal of surgical pathology.

Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.

L. Pantanowitz, S. Dacic, N. P. Ohori, 2015, American journal of clinical pathology.

Overexpression of p53 protein is common in premalignant head and neck lesions.

S. Dacic, K. Pavelić, J. Mcdonald, 1994, Anticancer research.

Malignancies incidentally detected at lung transplantation: radiologic and pathologic features.

S. Dacic, J. Pilewski, D. Strollo, 2013, AJR. American journal of roentgenology.

Evaluation of Small Biopsy Material in Patients with Multiple and Secondary Tumors

S. Monaco, S. Dacic, 2015 .

Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.

S. Dacic, A. Argiris, S. Gadgeel, 2009, Oncology.

Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation

Jian Yu, J. Siegfried, S. Dacic, 2007, Clinical Cancer Research.

THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer

Adrian V. Lee, Simion I. Chiosea, R. Dhir, 2017, Proceedings of the National Academy of Sciences.

Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification

S. Monaco, S. Dacic, E. Rodriguez, 2013, Cancer Cytopathology.

Hyperbaric Oxygenation Prevents Loss of Immature Neurons in the Adult Hippocampal Dentate Gyrus Following Brain Injury

S. Dacic, M. Djelic, R. Jeremic, 2023, International journal of molecular sciences.

Hyperbaric Oxygen Therapy in Traumatic Brain Injury: Cellular and Molecular Mechanisms

S. Dacic, M. Djelic, R. Jeremic, 2018, Hyperbaric Oxygen Treatment in Research and Clinical Practice - Mechanisms of Action in Focus.

The Importance of 10q Status in an Outcomes-Based Comparison Between 1p/19q Fluorescence In Situ Hybridization and Polymerase Chain Reaction–Based Microsatellite Loss of Heterozygosity Analysis of Oligodendrogliomas

S. Dacic, M. Nikiforova, C. Horbinski, 2012, Journal of neuropathology and experimental neurology.

Hyperbaric oxygenation improves locomotor ability by enhancing neuroplastic responses after cortical ablation in rats

L. Rakić, S. Dacic, A. Parabucki, 2012, Brain Injury.

Correlation of cytomorphology and molecular findings in EGFR+, KRAS+, and ALK+ lung carcinomas.

L. Pantanowitz, S. Monaco, S. Dacic, 2014, American journal of clinical pathology.

Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis

A. Dulak, J. Siegfried, S. Dacic, 2008, Molecular Cancer Therapeutics.

Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification

L. Pantanowitz, S. Monaco, S. Dacic, 2015, Cancer cytopathology.

Widespread Molecular Alterations Present in Stage I Non-Small Cell Lung Carcinoma Fail to Predict Tumor Recurrence

J. Luketich, S. Dacic, S. Finkelstein, 2003, Modern Pathology.

Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population.

Naobumi Tochigi, Marina Nikiforova, S. Dacic, 2011, American journal of clinical pathology.

Tumor Mutation Burden: Promises and Challenges A Perspective from the IASLC Pathology Committee.

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Repetitive Hyperbaric Oxygenation Attenuates Reactive Astrogliosis and Suppresses Expression of Inflammatory Mediators in the Rat Model of Brain Injury

S. Dacic, A. Parabucki, D. Savic, 2015, Mediators of inflammation.

Effect of stab injury in the rat cerebral cortex on temporal pattern of expression of neuronal cytoskeletal proteins: an immunohistochemical study.

S. Dacic, A. Parabucki, D. Savic, 2015, Acta histochemica.

Molecular Pulmonary Pathology

S. Dacic, S. Yousem, 2009 .

Molecular Alterations in Atypical Adenomatous Hyperplasia Occurring in Benign and Cancer-bearing Lungs

S. Dacic, J. Hunt, Geeta S. Mantha, 2007, Diagnostic molecular pathology (Print).

Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis

S. Dacic, 2007, Expert review of molecular diagnostics.

Recovery of brain cholinesterases and effect on parameters of oxidative stres and apoptosis in quails (Coturnix japonica) after chlorpyrifos and vitamin B1 administration.

S. Dacic, J. Santibañez, S. Borozan, 2020, Chemico-biological interactions.

AIRP best cases in radiologic-pathologic correlation: pulmonary sarcoidosis complicated by aspergilloma formation.

S. Dacic, D. Strollo, Stamatis Kantartzis, 2012, Radiographics.

Regional changes in ectonucleotidase activity after cortical stab injury in rat.

L. Rakić, S. Dacic, N. Nedeljkovic, 2009, General physiology and biophysics.

A Grading system for invasive pulmonary adenocarcinoma: a proposal from the IASLC pathology committee.

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR Assays in Lung Cancer

S. Dacic, 2008, Advances in anatomic pathology.

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer.

D. Heron, J. Luketich, S. Dacic, 2013, Lung cancer.

State of the Art of Pathologic and Molecular Testing.

S. Dacic, 2023, Hematology/oncology clinics of North America.

Prognostic Biomarkers in Lung Cancer

S. Dacic, 2018 .

Lung cancer and the future of pathology.

S. Dacic, P. Cagle, 2011, Archives of pathology & laboratory medicine.

TIAZOFURIN MODULATES LIPOPOLYSACCHARIDE-ACTIVATED MICROGLIA IN VITRO

S. Dacic, T. Herdegen, N. Nedeljkovic, 2014 .

Pulmonary Pathology Society Perspective on the 2018 American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society (ATS/ERS/JRS/ALAT) Idiopathic Pulmonary Fibrosis Clinical Practice Guidelines.

A. Borczuk, M. Mino‐Kenudson, M. Beasley, 2020, Annals of the American Thoracic Society.

Disease Response with the Addition of Platinum-Based Chemotherapy to Pembrolizumab after Progression on Pembrolizumab Monotherapy in PD-L1-Expressing Non-Small Cell Lung Cancer.

S. Dacic, Christine A Garcia, L. Villaruz, 2018, Journal of Thoracic Oncology.

VITAMIN B COMPLEX AS A POTENTIAL THERAPEUTICAL MODALITY IN COMBATING PERIPHERAL NERVE INJURY

S. Dacic, S. Peković, D. Vučević, 2022 .

P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer

A. Nicholson, A. Borczuk, Guoan Chen, 2019, Journal of Thoracic Oncology.

A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.

N. Le Stang, S. Dacic, F. Tirode, 2022, Archives of pathology & laboratory medicine.

P03.02 Neoadjuvant Osimertinib with/without Chemotherapy vs Chemotherapy for EGFR Mutated Resectable NSCLC: NeoADAURA

M. Tsuboi, Y. Yatabe, S. Dacic, 2021 .

Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations.

S. Dacic, Somak Roy, M. Mehrad, 2017, Archives of pathology & laboratory medicine.

Evaluation of endobronchial ultrasound‐guided fine‐needle aspirations (EBUS‐FNA): Correlation with adequacy and histologic follow‐up

L. Pantanowitz, S. Monaco, S. Dacic, 2014, Cancer cytopathology.

Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer

A. Drilon, M. Fishbein, S. Dacic, 2023, Frontiers in Oncology.

Real-Time PCR and Immunocytochemical Study of Chondroitin Sulfate Proteoglycans after Scratch Wounding in Cultured Astrocytes / PCR I IMUNOCITOHEMIJSKA STUDIJA EKSPRESIJE HONDROITIN-SULFATNIH PROTEOGLIKANA NAKON POVREDE ASTROCITA U KULTURI

S. Dacic, A. Parabucki, I. Bjelobaba, 2013 .

Molecular Prognostic Markers of Lung Cancer

S. Dacic, Sanja Dacic, 2012 .

Lung carcinoma morphology or mutational profile: that is the question.

S. Dacic, 2011, Archives of pathology & laboratory medicine.

Revolution in lung cancer: new challenges for the surgical pathologist.

Philip T Cagle, A. Borczuk, L. Chirieac, 2011, Archives of pathology & laboratory medicine.

Broad SARS-CoV-2 cell tropism and immunopathology in lung tissues from fatal COVID-19

C. Cordon-Cardo, M. Fowkes, S. Dacic, 2020, medRxiv.

A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening

Vanathi Gopalakrishnan, David O Wilson, J. Siegfried, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Application of Fractal and Grey Level Co-Occurrence Matrix Analysis in Evaluation of Brain Corpus Callosum and Cingulum Architecture

Igor Pantic, S. Dacic, S. Pantic, 2014, Microscopy and Microanalysis.

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective from the IASLC Pathology Committee.

I. Wistuba, M. Mino‐Kenudson, F. Hirsch, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Ribavirin administration alters ectonucleotidase activities in experimental autoimmune encephalomyelitis.

L. Rakić, S. Dacic, N. Nedeljkovic, 2009, General physiology and biophysics.

Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients.

V. Rusch, J. Luketich, R. Ginsberg, 2001, The Annals of thoracic surgery.

the Harwood Academic Publishers imprint, part of The Gordon and Breach Publishing Group. Printed in Malaysia. Fluorescence Bronchoscopic Surveillance in Patients with a History of Non-Small Cell Lung Cancer

J. Luketich, S. Dacic, S. Yousem, 1999 .

HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization.

J. Davison, S. Dacic, K. Nason, 2012, American journal of clinical pathology.

MTE02.01 Update on WHO Classification and Staging of Lung Cancer

S. Dacic, 2018, Journal of Thoracic Oncology.

Molecular pathology of lung cancer

A. Borczuk, L. Chirieac, M. Beasley, 2012 .

Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung

A. Nicholson, A. Borczuk, A. Warth, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Idiopathic Pulmonary Fibrosis

J. Enghild, T. Petty, M. Martinelli, 2003 .

Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin.

S. Dacic, M. Duvnjak, N. Skroza, 1993, Life sciences.

Serum biomarker profiles as diagnostic tools in lung cancer.

Christopher J Langmead, David O Wilson, C. Langmead, 2011, Cancer biomarkers : section A of Disease markers.

Array comparative genomic hybridization analysis of solid pseudopapillary neoplasms of the pancreas

A. Krasinskas, S. Dacic, H. Zeh, 2008, Modern Pathology.

Persistent fever in a lung transplant patient.

S. Dacic, D. Ionescu, 2009, Archives of pathology & laboratory medicine.

Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3

M. Romkes, J. Weissfeld, S. Dacic, 2015 .

A comparison of ALK gene rearrangement and ALK protein expression in primary lung carcinoma and matched metastasis

Caitlyn A. Miller, S. Dacic, H. T. Trejo Bittar, 2017, Histopathology.

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.

M. Kris, I. Wistuba, N. Altorki, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to Go.

A. Borczuk, M. Mino‐Kenudson, M. Beasley, 2020, Archives of pathology & laboratory medicine.

Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis

A. Borczuk, M. Mino‐Kenudson, M. Beasley, 2020 .

Idiopathic Bronchiolocentric Interstitial Pneumonia

S. Dacic, S. Yousem, 2002, Modern Pathology.

Pulmonary preneoplasia.

S. Dacic, 2008, Archives of pathology & laboratory medicine.

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020 .

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

A. Iafrate, L. Chirieac, M. Mino‐Kenudson, 2009, Clinical Cancer Research.